logo-loader
viewAlliance Pharma PLC

Alliance Pharma CEO looks forward to continued good growth prospects

John Dawson, CEO of Alliance Pharma (LON:APH) tells Proactiveinvestors that the future is looking good. With sales rising at 19% compound pa over the last five years, rising profitability, falling debt and a "progressive dividend strategy", everything is there. John says that he and his team will just continue proving the business model, making more acquisitions and then let the market catch up.

Quick facts: Alliance Pharma PLC

Price: 77.5 GBX

AIM:APH
Market: AIM
Market Cap: £410.96 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Alliance Pharma PLC named herein, including the promotion by the Company of Alliance Pharma PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read